- ►annals.org [PDF] W Stremmel, R Ehehalt, F Autschbach, M … - Annals of internal medicine, 2007 - Am Coll Physicians Background: Although long-term steroid treatment is discouraged in ulcerative
colitis, alternatives are lacking when therapy with im- munosuppressant drugs
fails. An insufficient level of phosphatidyl- choline in colonic mucus is a ... Cited by 25 - Related articles - BL Direct - All 5 versions
[CITATION] Infliximab reduces colectomy in patients with moderate-to-severe ulcerative colitis: …
CW Lees, D Heys, GT Ho, CL Noble, AG Shand, … - Alimentary Pharmacology and Therapeutics, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 28 - Related articles - BL Direct - All 6 versions
S Schreiber, A Keshavarzian, KL Isaacs, J … - Gastroenterology, 2007 - Elsevier Background & Aims: Tetomilast (OPC-6535), a novel thiazole compound, inhibits
phosphodiesterase-4 and proinflammatory functions of leukocytes including
superoxide production and cytokine release. Methods: One hundred eighty-six ... Cited by 21 - Related articles - All 22 versions
S Plevy, B Salzberg, G Van Assche, M … - Gastroenterology, 2007 - Elsevier Background & Aims: To evaluate the safety and biological activity of visilizumab
(a humanized anti-CD3 monoclonal antibody) and to determine a maximum tolerated
dose in patients with severe ulcerative colitis that had not responded to 5 ... Cited by 44 - Related articles - All 46 versions
N Chande, JK MacDonald, JW McDonald - Cochrane database of systematic reviews (Online), 2007 - ncbi.nlm.nih.gov BACKGROUND: Ulcerative colitis is a chronic inflammatory bowel disease.
Corticosteroids and 5-aminosalicylates are the most commonly used therapies.
However, many patients require immunosuppressive therapy when their disease ... Cited by 13 - Related articles
E Musch, T Andus, M Malek, A Chrissafidou, … - Zeitschrift für Gastroenterologie, 2007 - ncbi.nlm.nih.gov INTRODUCTION: In some steroid refractory patients with active ulcerative colitis
(UC), treatment with immunosuppressive agents, such as cyclosporin, azathioprine
or 6-mercaptopurin is effective. However, there are patients who fail to ... Cited by 9 - Related articles - BL Direct - All 3 versions
L Peyrin-Biroulet, C Laclotte, X Roblin, MA … - World Journal of Gastroenterology, 2007 - wjgnet.com RESULTS: Four of 10 patients (40%) benefited from subsequent adalimumab therapy;
one patient achieved remission (CAI < 4) and 3 had clinical improvement at wk 4.
6 patients had no response (60%); 2 of 6 (33.3%) subsequently underwent ... Cited by 36 - Related articles - Cached - BL Direct - All 5 versions
SL Jakobovits, DP Jewell, SP Travis - Alimentary Pharmacology and Therapeutics, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 37 - Related articles - BL Direct - All 4 versions
